|
2019
|
Invention
|
Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use the... |
|
2018
|
Invention
|
Gemcabene compositions and methods of use thereof.
The present invention provides pharmaceutical... |
|
|
Invention
|
Gemcabene compositions and methods of use thereof. The present invention provides pharmaceutical ... |
|
|
Invention
|
Gemcabene combinations for the treatment of cardiovascular disease.
The present invention provid... |
|
|
Invention
|
Effect of carboxyalkylethers on obesity symptoms and lipodystropy. Methods of treating obesity sy... |
|
|
Invention
|
Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ether... |
|
2017
|
Invention
|
Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy. Me... |
|
|
Invention
|
Treatment of patients with homozygous familial hypercholesterolemia on lipid-lowering therapy.
|
|
2016
|
Invention
|
Treatment of mixed dyslipidemia. Methods and formulations to reduce elevated levels of lipids and... |
|
|
Invention
|
Gemcabene combinations for the treatment of cardiovascular disease. The present invention provide... |
|
|
P/S
|
Pharmaceutical preparations in the field of cholesterol reduction, lipid disorders, hypertriglyce... |
|
2015
|
Invention
|
Processes and intermediates for preparing α,ω-dicarboxylic acid-terminated dialkane ethers. The p... |
|
|
Invention
|
Processes and intermediates for preparing alpha, omega-dicarboxylic acid-terminated dialkane ethe... |
|
2013
|
Invention
|
Methods of reducing risk of cardiovascular disease. Methods of lowering the plasma LDL-C le... |
|
2011
|
Invention
|
Gemcabene and derivatives thereof for treating or preventing pancreatitis. Gemcabene, a carboxyal... |
